EUVIMEDEUVIMED entdecken
Crossref

Discovery of a Meisoindigo-Derived PROTAC as the ATM Degrader: Revolutionizing Colorectal Cancer Therapy via Synthetic Lethality with ATR Inhibitors

Ting-Ting Liu, Qing Wang, Yuxing Zhou, Baixin Ye, Tingting Liu, Linyang Yan, Jinbao Fan, Jiahao Xu, Yingjun Zhou, Zanxian Xia iD, Xu Deng iD

Journal of Medicinal Chemistry · 09.05.2024 · 67 (9) · 7620-7634

DOI: 10.1021/acs.jmedchem.4c00454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 18.04.2024. Verfasst von Ting-Ting Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South Unive…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ataxia Telangiectasia Mutated Proteins, Colorectal Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Department of Science and Technology of Hunan Province, National Key Research and Development Program of China, Science Fund for Distinguished Young Scholars of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Meisoindigo (Mei) has long been recognized in chronic myeloid leukemia (CML) treatment. To elucidate its molecular target and mechanisms, we embarked on designing and synthesizing a series of Mei-derived PROTACs. Through this endeavor, VHL-type PROTAC 9b was identified to be highly cytotoxic against SW620, SW480, and K562 cells. Employing DiaPASEF-based quantitative proteomic analysis, in combination with extensive validation assays, we unveiled that 9b potently and selectively degraded ATM across SW620 and SW480 cells in a ubiquitin-proteasome-dependent manner. 9b-induced selective ATM degradation prompted DNA damage response cascades, thereby leading to the cell cycle arrest and cell apoptosis. This pioneering discovery renders the advent of ATM degradation for anti-cancer therapy. Notably, 9b-induced ATM degradation synergistically enhanced the efficacy of ATR inhibitor AZD6738 both in vitro and in vivo. This work establishes the synthetic lethality-inducing properties of ATR inhibitors in the ATM-deficient context, thereby providing new avenues to innovative therapies for colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAtaxia Telangiectasia Mutated ProteinsColorectal NeoplasmsAnimalsHumansMiceApoptosisCell Line, TumorCell ProliferationDrug DiscoveryIndolesMice, NudeProteolysisPyrimidinesStructure-Activity RelationshipSynthetic Lethal Mutations

Substanzen

Antineoplastic AgentsAtaxia Telangiectasia Mutated ProteinsIndolesPyrimidines

Autor:innen und Institutionen

  • Xiangya School of Pharmaceutical Sciences, Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha, Hunan 410013, China.
  • Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 311106, China.
  • School of Life Sciences, Central South University, Changsha, Hunan 410013, China.

ORCID-Profile: Zanxian Xia, Xu Deng

Förderung

  • Department of Science and Technology of Hunan Province
  • National Key Research and Development Program of China
  • Science Fund for Distinguished Young Scholars of Hunan Province
  • National Natural Science Foundation of China
  • Key Project of Research and Development Plan of Hunan Province

Zitieren

APA

Liu, T. T., Wang, Q., Zhou, Y., Ye, B., Liu, T., Yan, L., Fan, J., Xu, J., Zhou, Y., Xia, Z., & Deng, X. (2024). Discovery of a Meisoindigo-Derived PROTAC as the ATM Degrader: Revolutionizing Colorectal Cancer Therapy via Synthetic Lethality with ATR Inhibitors. Journal of Medicinal Chemistry, 67(9), 7620-7634. https://doi.org/10.1021/acs.jmedchem.4c00454

Vancouver

Liu TT, Wang Q, Zhou Y, Ye B, Liu T, Yan L, et al. Discovery of a Meisoindigo-Derived PROTAC as the ATM Degrader: Revolutionizing Colorectal Cancer Therapy via Synthetic Lethality with ATR Inhibitors. Journal of Medicinal Chemistry. 2024;67(9):7620-7634. doi:10.1021/acs.jmedchem.4c00454

BibTeX
@article{Liu2024,
  author = {Liu, Ting-Ting and Wang, Qing and Zhou, Yuxing and Ye, Baixin and Liu, Tingting and Yan, Linyang and Fan, Jinbao and Xu, Jiahao and Zhou, Yingjun and Xia, Zanxian and Deng, Xu},
  title = {Discovery of a Meisoindigo-Derived PROTAC as the ATM Degrader: Revolutionizing Colorectal Cancer Therapy via Synthetic Lethality with ATR Inhibitors},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {9},
  pages = {7620--7634},
  doi = {10.1021/acs.jmedchem.4c00454}
}
Kostenlos starten →